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Background​: Human microbiome research is interdisciplinary, making concise organizing and 
reporting of results across the different styles of epidemiology, biology, bioinformatics, and 
statistics a challenge. Commonly used reporting guidelines for observational or genetic studies 
lack key aspects specific to microbiome studies. 
Methods ​: A multidisciplinary group of microbiome researchers reviewed elements of available 
reporting guidelines for observational and genetic studies, and adapted these for application to 
human microbiome studies. New reporting elements were developed for laboratory, 
bioinformatic, and statistical analysis specific to microbiome studies, and other parts of these 
checklists were streamlined to keep reporting manageable. 
Results​: STORMS is a 18-item checklist for reporting on human microbiome studies, organized 
into six sections covering all sections of a scientific publication, presented as a table with space 
for author-provided details and intended for inclusion in supplementary materials.  
Conclusions ​: STORMS provides guidance for authors and standardization for interdisciplinary 
microbiome studies, facilitating complete and concise reporting. 
 
Availability ​: STORMS is downloadable as a versioned spreadsheet from ​storms.waldronlab.io ​.  
Introduction 
Reporting the results of human microbiome research is challenging because it often            
involves approaches from microbiology, genomics, biomedicine, bioinformatics, statistics, and         
epidemiology. Combined with the novelty of the field, this has resulted in the development and               
application of a variety of methodological approaches, with inconsistent reporting of methods            
and results. While some efforts have been made to address reporting standards in microbiome              
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studies, (1) no comprehensive standardized guidelines spanning laboratory and epidemiological          
reporting have been proposed. 
 
Reporting guidelines promote consistency in reporting and, as a consequence,          
encourage reproducibility and improved study design. Editorial adoption of the CONsolidated           
Standards Of Reporting Trials (CONSORT) guidelines, for example, has been associated with            
an increase in trial quality scores.(1,2) Other epidemiological reporting guidelines have seen            
broad adoption, such as Strengthening the Reporting of OBservational studies in Epidemiology            
(STROBE) and STrengthening the REporting of Genetic Association Studies (STREGA). The           
Enhancing the Quality and Transparency of health Research (EQUATOR) website lists over 400             
research reporting guidelines, but none as of the time of writing address studies of the human                
microbiome and health.(3)  
 
Epidemiological studies of the human microbiome face special considerations compared          
to other epidemiological studies and thus require specific reporting standards. In addition to             
standard elements of epidemiological study design, microbiome studies involve collection and           
handling of biological specimens, evolving approaches to laboratory processing with the           
potential for batch effects, bioinformatic processing, statistical analysis of high-dimensional data,           
and reporting of results on potentially thousands of microbial measures.(4–6) The field has not              
reached consensus on many of these aspects, so inconsistencies in reporting inhibit            
reproducibility and hamper efforts to draw conclusions across similar studies. 
 
For these reasons, we convened a multi-disciplinary working group to develop guidelines            
for microbiome study reporting. Members of this group include epidemiologists, biostatisticians,           
bioinformaticians, and microbiologists. The checklist is designed to balance completeness with           
burden of use, and is applicable to a broad range of human microbiome study designs and                
analysis. The “Strengthening The Organizing and Reporting of Microbiome Studies (STORMS)”           
checklist can serve as a tool to organize study planning and manuscript preparation, to improve               
the clarity of manuscripts, and for reviewers and readers to assess these studies. 
Methods 
Origin and development 
The origins of this project are rooted in a systematic review of papers examining the role                
of various microbiome sites and disease. The goal of this project is to curate and release a                 
publicly available, standardized database of microbiome study findings to aid future research.            
This review has revealed a large amount of heterogeneity in reporting, particularly around             
concepts of epidemiology such as study design, confounding, and sources of bias, but also              
microbiome-specific issues around statistical approaches to test for and measure relative           
abundance, and the extent to which potential bias from batch exists are addressed. This              
heterogeneity highlighted the need for standardized reporting guidelines, similar to those used            
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in other fields of study. The curators determined that standardized reporting guidelines would             
streamline the review process, but would more importantly help researchers throughout the field             
of microbiome research communicate their findings effectively. 
 
A multidisciplinary group of bioinformaticians, epidemiologists, biostatisticians, and        
microbiologists was convened to discuss microbiome reporting standards. The group began by            
reviewing existing study reporting standards including STROBE,(7) STREGA,(8) MICRO,(4) and          
STROGAR.(5) The group also reviewed existing articles containing recommendations for          
microbiome reporting.(9,10) The STROBE and STREGA guidelines were used as a starting            
point for the STORMS checklist, although inspiration was drawn from the other reporting             
standards reviewed as well.  
 
Working along the reporting standards development guidelines recommended by         
EQUATOR, a comprehensive list of potential guideline items was created. From this list, group              
members added, modified, and removed items based on their expertise. After the first round of               
edits, the checklist was then applied to a recent microbiome study by group members.              
Comments, removals, and additions were harmonized after each round. Based on this process,             
additional changes, simplifications, and clarifications were made with the goal of creating a             
streamlined and user-friendly checklist. This process was repeated until there was a group             
consensus that the checklist was ready for use. Outside subject matter experts were invited to               




The latest version of the checklist at time of publication is presented in Table 1. Of the items in 
the latest version in the STORMS checklist, nine items or subitems were unchanged from 
STROBE, five were modified from STROBE, one was modified from STREGA, and 27 new 
guidelines were developed. Rationale for new and modified items are presented below. 
Documentation of items unmodified from STROBE and STREGA were presented in the 
publications of those checklists. 
Abstract 
Along with commonly included abstract materials such as a basic description of the participants 
and results, authors should report the study design(11)--such as case-control, cohort, or 
randomized control trial--in the abstract of their article (Item 1.0), as required by other reporting 
guidelines. Communicating study design in the abstract allows readers to quickly categorize the 
type of evidence provided. 
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Introduction 
The introduction should clearly describe the underlying background, evidence, or theory that 
motivated the current study (Item 2.0). Among other possibilities, this could include pilot study 
data, previous findings from a similar study or topic, or a biologically plausible mechanism that 
has been proposed. This clarifies for the reader the motivations for the present study. If the 
study is exploratory in nature, explain what motivated the current exploration and the goals of 
the exploratory study. 
Methods 
Participants 
The methods section should contain sufficient information for study replicability. When 
describing the participants in the study, the population of interest should be described and then 
how participants were sampled from the target population should be reported (Item 3.0). 
Because participant characteristics such as environment,(12) demographics,(13) and 
geography(14) can have important effects on the microbiome, it is essential to include this 
description. Specific criteria used to assess potential participants for eligibility in the study 
should also be reported, including both inclusion and exclusion criteria (Item 3.1). This is 
expanded from STROBE which requires eligibility criteria, but does not specify that both 
inclusion and exclusion criteria should be reported in detail. 
 
The final analytic sample size should be stated and the reason for any exclusion of participants 
at any step of the recruitment or laboratory processes (Item 3.2). STROBE suggests using a 
flow diagram to show when and why participants were removed from the study. If participants 
were lost to follow-up or did not complete all assessments in a longitudinal study, time-point 
specific sample sizes should also be reported (Item 3.3). Additionally, studies that matched 
exposed to unexposed participants should describe what variables were used in matching (Item 
3.4). 
Laboratory 
Describe laboratory methods in sufficient detail to allow replication. The handling of lab samples 
should be described, including sampling procedure (Item 4.0), storage, handling, processing, 
and contaminant analysis or negative controls (Item 4.3). Batch effects should be discussed as 
a potential source of confounding, including steps taken to ensure batch effects do not overlap 
with exposures or outcomes of interest (Item 4.1).(15) Library preparation, sequencing platform, 
and references to protocols with versions, should be stated (Item 4.4).  
Data sources/measurement 
For non-microbiome data (e.g. health outcomes, participant socioeconomic characteristics, 
environmental variables), the measurement of each variable should be described (Item 5.0). For 
instance, participant gender and age could be obtained from electronic medical records or from 
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a questionnaire distributed to participants; this data source should be described. Limitations of 
measurement may also be discussed including potential bias due to misclassification or missing 
data as well as any attempts made to address these measurement issues. 
Research design considerations for causal inference 
Observational data is often used to test associations that aim to infer cause and effect. Methods 
include, for example, the use of multivariable analysis or matching to adjust for confounding 
variables that lie on a common causal path between a hypothesized exposure (such as 
abundance of a microbial taxon) and the disease or condition under study. If variables are 
adjusted for in the analysis, theoretical justification for inclusion of these variables should be 
provided (Item 6.0). Consider including a directed acyclic graph showing the hypothesized 
causal relationships of interest.(16) Additionally discuss the potential for selection or survival 
bias (Item 6.1). For example, such bias may occur due to loss-to-follow-up (in longitudinal 
studies) or due to participants not being included in the study due to the condition itself (e.g. 
participants who have died of aggressive forms of colorectal cancer have not survived to be in a 
hypothetical study of colorectal cancer microbiomes).(17) 
Bioinformatics and Statistical Methods 
Adequate description of bioinformatic and statistical methods is essential to producing a 
rigorous and reproducible research report. Transformations of quantitative variables (such as 
normalization, rarefaction, and percentages) should be described (Item 7.0). All statistical 
methods used to analyze the data should be stated, (Item 7.1) including how results of interest 
were selected (e.g. using a p-value or other threshold) (Item 7.6). In the interest of 
reproducibility, all software, packages, databases, and libraries used for the analysis of the data 
should be described and cited including version numbers (Item 7.7). 
Results 
Outcome Data 
The main outcomes of the study should be detailed including descriptive information, findings of 
interest, and the results of any additional analyses. Descriptive microbiome analysis (for 
instance, dimension reduction such as Principal Coordinates Analysis, measures of diversity, 
gross taxonomic composition) should be reported for each group and each time point (Item 9.0). 
This contextualizes the results of differential abundance analysis for readers. When reporting 
differential abundance test results, the magnitude and direction of differential abundance should 
be clearly stated (Item 9.1) for each identifiable standardized taxonomic unit (Item 9.2). Some 
results (e.g. non-significant results) can be included in supplements, but should not be excluded 
entirely. Although the problem has been known for decades,(18) journals across many fields are 
recognizing the issue of publication bias and therefore the issue of non-reporting of null 
results.(19) Including such results in publications will help to reduce the severity of this bias and 
improve future systematic reviews and meta-analyses. 
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Discussion 
Most recommendations for the Discussion section remain unchanged from STROBE. One 
additional recommendation is made: discuss the potential for bias and how they would influence 
the study findings (Item 12.1). Many forms of bias such as measurement bias or selection 
bias(20) could affect the interpretation of the results of the study and it is important to 
acknowledge potential sources of bias when discussing the results.(21) If different forms of bias 
were not assessed or assumed to be negligible, this should be stated. 
Other Information 
Reproducible research practices serve as quality checks in the process of publication and 
further transparency and knowledge sharing.(18) Journals are increasingly implementing 
reproducible research standards that include the publishing of data and code and those 
guidelines should be followed when possible.(23,24) STORMS itemizes the accessibility of data 
and code (Items 18.0 through 18.4). If data or code are not made publicly available, an 
explanation should be given. 
Discussion 
The STORMS guidelines can improve the quality and communication of studies of the             
human microbiome, by introducing a shared grammar of study reporting for the field. They              
encourage reproducibility and open data sharing, and ease barriers to conducting systematic            
reviews and meta-analyses. The development of STORMS is an ongoing process and new             
versions of the checklist will be released to reflect evolving standards and technological             
processes. We invite interested readers to join the working group by contacting the             
corresponding author or by visiting the working group website for more information            
(​storms.waldronlab.io ​). We also encourage journals to include the STORMS checklist in their            
instructions to authors and advise peer reviewers to consult the checklist when reviewing             
submissions. 
 
There are some limitations to the STORMS checklist. The checklist was not created to              
assess study or methodological rigor. It is meant to make it easy for readers to assess how a                  
study was conducted and analyzed. Conclusions about the quality of studies should not be              
made based on their adherence to STORMS guidelines, although it is our hope that the               
reporting guidelines will help readers review studies critically. It does not encourage,            
discourage, or assume the use of null hypothesis significance testing(22) or methods of             
compositional data analysis,(23) topics of some controversy in the field. In general the checklist              
avoids reference to or guidance on specific statistical methodological decisions. 
 
The working group believes that the STORMS checklist is sufficiently flexible and            
“user-friendly” to support widespread adoption and contribution to microbiome study standards.           
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Its adoption will encourage thoughtful study design, study reproducibility, collaboration, and           
open knowledge sharing between research groups as they explore the human microbiome. 
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Number Item Recommendation Source Additional Guidance Yes/No/NA Comments Relevant Text from article
Abstract
1.0 Study Design Study design is stated in the abstract. STORMS
Examples: case-control (participants with condition of 
interest are matched to controls), cross-sectional (data 
collected at one time point, no matching done between 
cases and controls), randomized controlled trial (condition 
is randomly assigned to participants), time series 
(participants are followed over time to observe changes), 
cohort (participants are followed over time to see who 
develops the condition of interest and who does not). For 
more information about common study designs see: https:
//doi.org/10.1592/phco.30.10.973
Introduction
2.0 Background and Rationale
State underlying background, scientific evidence, or theory driving the 




State what the population of interest is, and the method by which 
participants are sampled from that population. STORMS
Examples of the population of interest could be: adults 
with no chronic health conditions, adults with type II 
diabetes, newborns, etc. This is the total population to 
whom the study is hoped to be generalizable to. The 
sampling method describes how potential participants 
were selected from that population.
This includes the geographic region where participants 
were sampled from.
3.1     Eligibility criteria List any criteria for inclusion and exclusion of recruited participants. Modified STROBE
Among potential recruited participants, how were some 
chosen and others not?
3.2     Analytic sample size
Explain how the final analytic sample size was calculated, including the 
number of cases and controls if relevant, and reasons for dropout at 
each stage of the study. This should include the number of individuals 
in whom microbiome sequencing was attempted and the number in 
whom microbiome sequencing was successful. STORMS Consider use of a flow diagram (from STROBE).
3.3     Loss to follow-up
For longitudinal studies, describe sample size at follow-up by group or 
condition and discuss any loss to follow-up. STORMS
If there is loss to follow-up, discuss the likelihood that 
drop-out is associated with exposures, treatments, or 
outcomes of interest.
3.4     Matching For matched studies, give matching criteria. Modified STROBE
"Matched" refers to matching between comparable study 
participants as cases and controls or exposed / 
unexposed.
4.0 Laboratory State the body site sampled from and how samples were collected. STORMS
4.1     Batch effects
Discuss any likely sources of batch effects, if known. Detail any 
blocking or randomization used in study design to avoid confounding of 
batches with exposures or outcomes. STORMS
Batch effects are unavoidable in all but the smallest 
genomic studies, and can be introduced by subtle 
differences in sample collection, storage, library 
preparation, and sequencing.
4.2     Storage
Storage. State the laboratory/center where laboratory work was done. 
Describe how the laboratory stored samples, including time between 
collection and storage as well as any preservation buffers used. STORMS
State where each procedure or lot of samples was done if 
not all in the same place.
4.3     Laboratory methods
Describe laboratory methods including (where relevant): collection, 
shipping, extraction (including kit and version), human DNA removal (if 
applicable), amplification, primer selection, and contaminant 
analysis/negative controls. STORMS
For amplicon sequencing (for example, 16S variable 
region), state the region selected. If enrichment is 
performed (e.g. for viromes), include here.
Note any modifications of lab protocols and the reason for 
protocol modifications.
4.4     Sequencing
Describe sequencing methods and platforms as well as any profiling 
software used (name and version). STORMS
4.5     Controls Describe positive and negative controls used in extraction, sequencing, 
preprocessing, and/or analysis. STORMS
5.0 Data sources/
measurement 
For each non-microbiome variable, including the health condition of 
interest, state how it was measured or collected. STORMS
State any sources of potential bias in measurements, for 
example multiple interviewers or measurement 
instruments, and whether these potential biases were 
assessed or accounted for in study design.
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Number Item Recommendation Source Additional Guidance Yes/No/NA Comments Relevant Text from article
6.0 Research design for causal inference
State which variables are controlled and state the rationale for 
controlling for them within your hypothesized causal framework. STORMS
For example, hypothesized confounders may be controlled 
for by multivariate adjustment, but colliders or mediators 
should not be. Consider using a Directed Acyclic Graph 
(DAG) to sumarize hypothesized causal pathways.
6.1     Selection bias
Discuss potential for selection or survival bias. STORMS
Selection bias can occur when some members of the 
target study population are more likely to be selected for 
the study than others. Some examples include survival 
bias (where part of the target study population is more 
likely to die before they can be studied), convenience 
sampling (where members of the target study population 
are not selected at random), and loss to follow-up (when 
probability of dropping out is related to one of the things 
being studied).
7.0 Bioinformatic and 
Statistical Methods
Describe any transformations to quantitative variables used in analyses 
(e.g. use of percentages instead of counts, normalization, rarefaction, 
categorization). STORMS
7.1     Statistical methods Describe all statistical methods. Modified STROBE
7.2     Subgroup analysis Describe any methods used to examine subgroups and interactions. STROBE
7.3     Missing data Explain how missing data were addressed. STROBE
7.4     Methods for sampling If applicable, describe methods taking into account of sampling 
strategy/survey design. Modified STROBE
This could include using methods that adjust for 
stratification, clustering, or sample weighting.
7.5     Sensitivity analyses Describe any sensitivity analyses. STROBE
7.6     Findings
State criteria used to select findings for reporting. STORMS
For example, false discovery rate with total number of 
tests, effect size threshold, significance threshold, 
microbes of interest.
7.7     Software
Cite all software (including read mapping software) and databases 
(including any used for annotating amplicons, if applicable) used. 
Include version numbers. Modified STREGA
For R, installed package versions should be stated and 
cited in addition to the version of R used. 
Results
8.0 Descriptive Data
Give characteristics of study participants (e.g. dietary, demographic, 
clinical, social) and information on exposures and potential 
confounders. STROBE
Typically reported in Table 1. Indicate number of 
participants with missing data for each variable of interest
This includes environmental and lifestyle factors that may 
be important to the relationship between the microbiome 
and the condition of interest. Participant diet and 
medication use should be summarized, if known.
At the very minimum, age and sex of all participants 
should be reported.
9.0 Outcome Data Report descriptive findings for microbiome analyses by group and (if 
applicable) by time. STORMS
9.1     Differential abundance Report results of differential abundance analysis by group and (if 
applicable) by time, clearly indicating the direction of change. STORMS
9.2     Taxonomy
Identify taxonomy using standardized taxon classifications that are 
sufficient to uniquely identify taxa. STORMS
If not using full taxonomic hierarchy, make sure it is clear 
whether names stated are species, genera, family, etc. 
Italicize genus/species pairs.
10.0 Other analyses Report other analyses done—e.g. analyses of subgroups and 
interactions, and sensitivity analyses. STROBE
Discussion
11.0 Key results Summarise key results with reference to study objectives STROBE
12.0 Limitations Discuss limitations of the study, taking into account sources of potential 
bias or imprecision. STROBE
12.1 Discuss any potential for bias to influence study findings. STORMS
13.0 Interpretation Give a cautious overall interpretation of results considering objectives, 
limitations, multiplicity of analyses, results from similar studies, and 
other relevant evidence. STROBE
Define or clarify any subjective terms such as "dominant," 
"dysbiosis," and similar words used in interpretation of 
results.
14.0 Generalizability Discuss the generalisability (external validity) of the study results STROBE
Other information
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Number Item Recommendation Source Additional Guidance Yes/No/NA Comments Relevant Text from article
15.0 Funding Give the source of funding and the role of the funders for the present 
study and, if applicable, for the original study on which the present 
article is based STROBE
16.0 Supplements Indicate where supplements may be accessed and what materials they 
contain STORMS
17.0     Supplementary data
Provide a supplementary spreadsheet of results with for all taxa and all 
outcome variables analyzed. Indicate the taxonomic level of all taxa. STORMS
Depending on the analysis performed, examples of the 
supplemental results included could be mean relative 
abundance, differential abundance, raw p-value, MHT-
adjusted p-values, and standard error.
All discussed taxa should include the taxonomic level (e.g. 
class, order, genus)
18.0 Reproducible research (a) State where raw data may be accessed including demultiplexing 
information. STORMS
18.1     Processed data access (b) State where processed data may be accessed. STORMS
18.2     Participant data access (c) State where participant data may be accessed. STORMS
18.3     Source code access (d) State where code may be accessed. STORMS
18.4     Full results
(e) Provide full results of all analyses, in computer-readable format, in 
supplementary materials. STORMS
For example, any fold-changes, p-values, or FDR values 
calculated. 
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